Phynova has established several research and corporate collaborations including associations formed via the prestigious Innovate UK grant that was awarded to Phynova in 2013.
Research & Development Collaboration
Campden BRI provides practical scientific, technical, legislative and information support to the food, drink and allied industries. Phynova is a member of the organisation and is engaged with the company for many projects based on IminoNorm®.
ElexoPharm is a German biopharmaceutical company that specializes in Hit Discovery, Lead Finding and Lead Optimization. Phynova has collaborated with ElexoPharm for co-development of the chronic wound healing botanical extract PYN 16.
The NHS trust provides services to some 1.9 million people living in Southampton and south Hampshire and provides specialised services in cardiac services. They are in collaboration for conducting human studies for IminoNorm®.
Guangzhou Xiangxue Pharmaceuticals Co. is one of the largest pharma companies for R&D, manufacturing and marketing of Traditional Chinese Medicine products (TCM). Phynova is expanding their reach to the EU by registering their products in the UK.